Invasive Group A Streptococcal Infection in Children, 1992-2023
JAMA Network Open · 01.04.2025 · 8 (4) · e252861
DOI: 10.1001/jamanetworkopen.2025.2861 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 01.04.2025. Verfasst von Halima Dabaja-Younis und 42 weiteren Autor:innen. Beteiligte Einrichtung: Infection Prevention and Control Unit, Sinai Health, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Streptococcal Infections, Streptococcus pyogenes. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Importance The resurgence of invasive group A streptococcal (iGAS) infections and progress in GAS vaccine development emphasize the importance of understanding current trends in the epidemiology of iGAS.
Objective
To describe the epidemiology of pediatric iGAS over a 32-year period. Design, Setting, and Participants This case series uses population-based surveillance data for iGAS in Toronto and Peel Region, Canada, including emm typing from Canada’s National Microbiology Laboratory and population data from Statistics Canada. All children (age <18 years) with iGAS from January 1, 1992, to December 31, 2023, were included. Data were analyzed from July 15, 2023, to September 1, 2024. Main Outcomes and Measures Outcomes of interest were disease incidence over time and by age; variation in clinical presentation, disease severity, outcomes and infecting emm types; and antimicrobial resistance.
Results
Overall, 498 iGAS cases (300 [60.2%] male; median [IQR] age, 5.1 [2.7-8.6] years) occurred, including 151 (30.7%) in children with comorbidities. The most common presentations were soft tissue infection (140 cases [28.1%]) and bacteremia without focus (131 cases [26.3%]). iGAS incidence increased from 1.8 events per 100 000 population per year in 1992 to 2011 to 2.4 events per 100 000 population per year in 2012 to 2019 (incidence rate ratio, 1.3 [95% CI, 1.1-1.6]), with the increase occurring in GAS infections of the respiratory tract. Incidence declined to 1.2 events per 100 000 population per year in 2020 and 0.5 events per 100 000 population per year in 2021 before increasing to 6.0 events per 100 000 population per year in 2023. In 2022 to 2023, 18 of 56 children with iGAS (32.0%) had a viral respiratory coinfection. Varicella-associated iGAS cases declined from 23 of 137 children (16.8%) in 1992 to 2001 to 2 of 223 children (0.9%) in 2012 to 2023 ( P < .001), after routine varicella vaccination implementation in 2004. Streptococcal toxic shock syndrome occurred in 29 children (5.8%), necrotizing fasciitis in 12 children (2.4%); 10 children (2.0%) died. The most common emm types were emm 1 (182 of 471 isolates [38.6%]), emm 12 (75 isolates [15.9%] ), and emm 4 (31 isolates [6.6%]). The M1 UK subtype was first identified in 2019 and comprised 32 of 46 emm 1 isolates (70.0%) from 2019 to 2023. Compared with other emm types, emm 1 was more likely to be associated with pneumonia (odds ratio [OR], 1.99 [95% CI, 1.16-3.40]), bone and joint infections (OR, 1.70 [95% CI, 1.08-2.68]), and intensive care unit admission (OR, 1.67 [95% CI, 1.03-2.68]); emm 4 was more likely to be associated with bacteremia without focus (OR, 6.10 [95% CI, 2.83-13.16]). Overall, 437 isolates (92.8%) were of emm types included in the 30-valent GAS vaccine. Conclusions and Relevance This case series found that pediatric iGAS incidence increased in south-central Ontario prior to and after the COVID-19 pandemic in association with increased iGAS infections of the respiratory tract. Respiratory viral coinfections were common. Different emm types were associated with differing presentations and severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Infection Prevention and Control Unit, Sinai Health, Toronto, Ontario, Canada.
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
- Michael Garron Hospital, Toronto East Health Network, Toronto, Ontario, Canada.
- Department of Microbiology, Sinai Health, Toronto, Ontario, Canada.
- Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Toronto Public Health, Toronto, Ontario, Canada.
Zitieren
APA
Dabaja-Younis, H., Kandel, C., Green, K., Johnstone, J., Zhong, Z., Kassee, C., Allen, V., Armstrong, I., Baqi, M., Barker, K., Bitnun, A., Borgia, S., Campigotto, A., Chakrabarti, S., Gold, W. L., Golden, A., Kitai, I., Kus, J., Macdonald, L., …, & Toronto Invasive Bacterial Diseases Network (2025). Invasive Group A Streptococcal Infection in Children, 1992-2023. JAMA Network Open, 8(4), e252861. https://doi.org/10.1001/jamanetworkopen.2025.2861
Vancouver
Dabaja-Younis H, Kandel C, Green K, Johnstone J, Zhong Z, Kassee C, et al. Invasive Group A Streptococcal Infection in Children, 1992-2023. JAMA Network Open. 2025;8(4):e252861. doi:10.1001/jamanetworkopen.2025.2861
BibTeX
@article{DabajaYounis2025,
author = {Dabaja-Younis, Halima and Kandel, Christopher and Green, Karen and Johnstone, Jennie and Zhong, Zoe and Kassee, Caroline and Allen, Vanessa and Armstrong, Irene and Baqi, Mahin and Barker, Kevin and Bitnun, Ari and Borgia, Sergio and Campigotto, Aaron and Chakrabarti, Sumon and Gold, Wayne L and Golden, Alyssa and Kitai, Ian and Kus, Julianne and Macdonald, Liane and Martin, Irene and Muller, Matthew and Nadarajah, Jeya and Ostrowska, Krystyna and Ricciuto, Daniel and Richardson, David and Saffie, Medina and Tadros, Manal and Tyrrell, Gregory and Varia, Monali and Almohri, Huda and Barati, Shiva and Crowl, Gloria and Farooqi, Lubna and Lefebvre, Maxime and Li, Angel Xinliu and Malik, Nadia and Pejkovska, Mare and Sultana, Asfia and Vikulova, Tamara and Hassan, Kazi and Plevneshi, Agron and McGeer, Allison and Toronto Invasive Bacterial Diseases Network, Toronto Invasive Bacterial Diseases Network},
title = {Invasive Group A Streptococcal Infection in Children, 1992-2023},
journal = {JAMA Network Open},
year = {2025},
volume = {8},
number = {4},
pages = {e252861},
doi = {10.1001/jamanetworkopen.2025.2861}
}
EUVIMED